Global women's health solutions company
DELIVERING INNOVATIONS TO YOUR TEAMS. ANYWHERE.
Our Solutions
Maternova licenses innovative femtech & medtech from startups.
We then make it easy for distributors, governments and humanitarian organizations to research, source and fulfill orders of trusted medical devices and diagnostics.
As seen in:
Anemia in Pregnancy: A Public Health Problem
Anemia and pregnancy: a public health problem Anemia is a condition characterized by a decrease in the concentration of red blood cells or hemoglobin below normal values. In pregnancy, due...
Read More
Can preeclampsia be prevented?
Can preeclampsia be prevented? Preeclampsia, defined as new onset of hypertension (≥140/90 mmHg), usually after 20 weeks of gestation associated with proteinuria, (1) complicates 2-3% of all pregnancies (2) and...
Read More
How I Survived Eclampsia through an Emergency Visit After a Birth in Borno State, Nigeria
Aisha Mohammed was an unbooked client-- she delivered at home in a remote village near Kidang town in Hawul LGA of Borno state Nigeria. Unbooked means that she had no...
Read More
In 2017 WHO added TXA to its Postpartum Hemorrhage Recommendations
The WOMAN Trial (World Maternal Antifibrinolytic Trial) was an international randomized double-blind, placebo controlled trial that began in 2010 to investigate the effect of early administration of tranexamic acid on morbidity, mortality,...
Read MoreOur Partners
The world's first global marketplace for lifesaving innovations
Maternova
TESTIMONIALS from our customers
CRADLE Vital Signs Alert (blood pressure device)
We have already found that for community health workers, this device is a big improvement over the traditional sphyngmamometers, which leave too much room for error.
Dr. Jean-Eric Calvaire, Medical Director, Care2Communities, Haiti
We are very aggressive in our management of postpartum hemorrhage. Using the NASG we have been able to stop postpartum hemorrhage and avoid blood transfusions
Mercy in Action, Philippines
{formbuilder:60191} 
